Clinical efficacy of DHS and PFNA for treatment of senile patients with intertrochanteric fracture and Parkin-son’ s disease
10.11659/jjssx.04E016102
- VernacularTitle:DHS和PFNA治疗合并帕金森病老年股骨粗隆间骨折的临床研究
- Author:
Hong REN
;
Wei XIAO
;
Tinggang WANG
;
Xiaobao REN
;
Wei WANG
- Publication Type:Journal Article
- Keywords:
Parkinson’ s disease;
intertrochanteric fracture;
dynamic hip screw;
proximal femoral nail anti-rotation
- From:
Journal of Regional Anatomy and Operative Surgery
2016;25(8):596-599
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the clinical efficacy of dynamic hip screw( DHS) and proximal femoral nail anti-rotation( PFNA) in treatment of patients with Parkinson’ s disease and intertrochanteric fracture. Methods A total of 62 elderly patients of Parkinson’ s disease with femoral intertrochanteric fracture in our hospital from February 2010 to February 2014 were divided into two groups according to different internal fixations,with 31 cases in DHS group and PFNA group respectively. The operation time,X-ray fluoroscopy times,intraoperatve blood soss,the healing time of fracture,postoperative complications and Harris score between two groups were recorded and compared statistically. Results The operation time,intraoperatve blood soss and the clinical healing time of PFNA group were significantly lower than those of DHS group,the differences were statistically significant (P<0. 05). But the times of intraoperative fluoroscopy of PFNA group was more than that of DHS group,the difference was statistically significant (P<0. 05). The Harris score of hip function results showed that the excellent rate of PFNA group was significantly higher than that of DHS group, the difference was statistically significant (P=0. 034). All patients were fol-lowed up for 6 to 48 months. There were 4 cases with complications after operation in DHS group,1 cases of complications in PFNA group,the difference in complications was not significant (P>0. 05). Conclusion The PFNA has the advantages of shorter operation time,less bleed-ing,faster healing time in treatment for elderly patients with Parkinson’ s disease and intertrochanteric fracture,worth clinical promotion.
